Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Viruses
|
November 25, 2023
Immune-Cell-Based Therapy for COVID-19: Current Status
Yiyuan Wang, Qinghe Liang, Fengsheng Chen, et al.
Pharmacological Research
|
August 15, 2025
Osteoclast precursor cell-derived Flot2 is a novel therapeutic target for bone loss diseases
Binhua Zou, Jiehuang Zheng, Weili He, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
October 14, 2023
Hexahydrocurcumin from Zingiberis rhizoma attenuates lipopolysaccharide-induced acute pneumonia through JAK1/STAT3 signaling pathway
Ruopeng Li, Qinghe Liang, Qin Yang, et al.
Biochemical Pharmacology
|
March 7, 2026
A resveratrol derivative RVX-208 inhibits PD-1/PD-L1 to restrain non-small cell lung cancer as an immunotherapy
Ziye Chen, Ruopeng Li, Fengsheng Chen, et al.
Biochemical Pharmacology
|
February 15, 2026
An allosteric SHP2 inhibitor suppresses breast cancer-induced osteoclastogenesis and bone lysis
Qinghe Liang, Wenqi Dai, Jiehuang Zheng, et al.
International Immunopharmacology
|
June 3, 2026
Kirenol, a diterpene active component from Siegesbeckia orientalis, alleviates atopic dermatitis by suppressing TYK2
Ziye Chen, Yuecheng Wang, Hongyan Guo, et al.
Pharmacological Research
|
October 20, 2022
IKKβ increases neuropilin-2 and promotes the inhibitory function of CD9<sup>+</sup> Bregs to control allergic diseases
Yiyuan Wang, Wende Deng, Juan Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 5, 2026
Hexahydrocurcumin inhibits osteoclastogenesis and bone destruction in osteoporosis by targeting c-Src
Lihong Li, Wenqi Dai, Zhuwei Zhong, et al.
Journal of Advanced Research
|
March 31, 2024
Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction
Jiehuang Zheng, Weili He, Yan Chen, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
May 10, 2024
Oroxylin A suppresses breast cancer-induced osteoclastogenesis and osteolysis as a natural RON inhibitor
Yan Chen, Jiehuang Zheng, Lixia Mo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Viruses
|
November 25, 2023
Immune-Cell-Based Therapy for COVID-19: Current Status
Yiyuan Wang, Qinghe Liang, Fengsheng Chen, et al.
Pharmacological Research
|
August 15, 2025
Osteoclast precursor cell-derived Flot2 is a novel therapeutic target for bone loss diseases
Binhua Zou, Jiehuang Zheng, Weili He, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
October 14, 2023
Hexahydrocurcumin from Zingiberis rhizoma attenuates lipopolysaccharide-induced acute pneumonia through JAK1/STAT3 signaling pathway
Ruopeng Li, Qinghe Liang, Qin Yang, et al.
Biochemical Pharmacology
|
March 7, 2026
A resveratrol derivative RVX-208 inhibits PD-1/PD-L1 to restrain non-small cell lung cancer as an immunotherapy
Ziye Chen, Ruopeng Li, Fengsheng Chen, et al.
Biochemical Pharmacology
|
February 15, 2026
An allosteric SHP2 inhibitor suppresses breast cancer-induced osteoclastogenesis and bone lysis
Qinghe Liang, Wenqi Dai, Jiehuang Zheng, et al.
International Immunopharmacology
|
June 3, 2026
Kirenol, a diterpene active component from Siegesbeckia orientalis, alleviates atopic dermatitis by suppressing TYK2
Ziye Chen, Yuecheng Wang, Hongyan Guo, et al.
Pharmacological Research
|
October 20, 2022
IKKβ increases neuropilin-2 and promotes the inhibitory function of CD9<sup>+</sup> Bregs to control allergic diseases
Yiyuan Wang, Wende Deng, Juan Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 5, 2026
Hexahydrocurcumin inhibits osteoclastogenesis and bone destruction in osteoporosis by targeting c-Src
Lihong Li, Wenqi Dai, Zhuwei Zhong, et al.
Journal of Advanced Research
|
March 31, 2024
Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction
Jiehuang Zheng, Weili He, Yan Chen, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
May 10, 2024
Oroxylin A suppresses breast cancer-induced osteoclastogenesis and osteolysis as a natural RON inhibitor
Yan Chen, Jiehuang Zheng, Lixia Mo, et al.
Page
of 2